Innovation & Investment Fund Gelderland
3
1M
2
1
0.33
- Stages of investment
- Areas of investment
Summary
The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Sanquin Blood Supply Foundation, OostNL. In the next rounds fund is usually obtained by RA Capital Management, Medicxi Ventures, INKEF Capital.
Among the most popular fund investment industries, there are Life Science, Information Technology. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight InteRNA Technologies, Xenikos.
The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 1 - 5 millions dollars. The important activity for fund was in 2013.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 1
- Follow on index
- 0.33
- Investments by industry
- Biotechnology (3)
- Therapeutics (3)
- Information Technology (2)
- Life Science (1)
- Investments by region
-
- Netherlands (1)
- United States (2)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Group Appearance index
- 0.33
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Xenikos | 19 Jun 2012 | Biotechnology, Life Science, Therapeutics | Early Stage Venture | 4M | Nijmegen, Gelderland, Netherlands |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.